Skip to main content
Official Logo of Columbia Business School
Academics
  • Visit Academics
  • Degree Programs
  • Admissions
  • Tuition & Financial Aid
  • Campus Life
  • Career Management
Faculty & Research
  • Visit Faculty & Research
  • Academic Divisions
  • Search the Directory
  • Research
  • Faculty Resources
  • Teaching Excellence
Executive Education
  • Visit Executive Education
  • For Organizations
  • For Individuals
  • Program Finder
  • Online Programs
  • Certificates
About Us
  • Visit About Us
  • CBS Directory
  • Events Calendar
  • Leadership
  • Our History
  • The CBS Experience
  • Newsroom
Alumni
  • Visit Alumni
  • Update Your Information
  • Lifetime Network
  • Alumni Benefits
  • Alumni Career Management
  • Women's Circle
  • Alumni Clubs
Insights
  • Visit Insights
  • Digital Future
  • Climate
  • Business & Society
  • Entrepreneurship
  • 21st Century Finance
  • Magazine

Wafaa El-Sadr

Chazen Institute Board
Jerome A. Chazen Institute for Global Business
Professor, Dr. Mathilde Krim-amfAR Chair of Global Health Epidemiology iIn ICAP)
Columbia University
Director
ICAP, Mailman School of Public Health, Columbia University
Wafaa El-Sadr

Dr. Wafaa El-Sadr is the founder and director of ICAP and an international expert in infectious diseases and public health with extensive experience in epidemiology and research on the prevention and management of HIV, tuberculosis, malaria, and emerging infections, among others. She is also the director of Columbia World Projects and director of the Mailman School's Global Health Initiative (GHI), which mobilizes the university community to address critical challenges in global health.

For over four decades, she has advocated for families and communities most impacted by health challenges and championed a collaborative, multidisciplinary approach to confronting the global epidemic. Based at Columbia University, she leads ICAP's portfolio of projects in more than 30 countries and manages a global team of over 2,000 staff. Under her leadership, ICAP has become a global leader in addressing global health challenges and health systems strengthening.

Dr. El-Sadr began her career as the HIV epidemic took hold in the United States. As chief of the Division of Infectious Diseases at Harlem Hospital, she developed successful methods for responding to HIV/AIDS through groundbreaking research and innovative models of care in her own community. Dr. El-Sadr became a leader in the global fight against HIV by arming healthcare systems around the world with effective strategies for confronting the impact of various health challenges and leveraging investment to strengthen health systems. She is the principal investigator for numerous ICAP-led research initiatives and a principal investigator of the NIH-funded HIV Prevention Trials Network (HPTN).

Dr. El-Sadr received her medical degree at Cairo University, a master's in public health (epidemiology) from Columbia University Mailman School of Public Health, and a master's in public administration from Harvard University Kennedy School of Government. She joined the faculty of Columbia's College of Physicians and Surgeons in 1988 and became a professor of epidemiology and medicine at the Mailman School of Public Health. In 2013, she was appointed University Professor, Columbia's highest academic title. She also holds the Dr. Mathilde Krim-amfAR Chair in Global. She is a MacArthur fellow, as well as a member of the National Academy of Medicine, the Council for Foreign Relations, and the African Academy of Sciences.

External CSS

Official Logo of Columbia Business School

Columbia University in the City of New York
665 West 130th Street, New York, NY 10027
Tel. 212-854-1100

Maps and Directions
    • Centers & Programs
    • Current Students
    • Corporate
    • Directory
    • Support Us
    • Recruiters & Partners
    • Faculty & Staff
    • Newsroom
    • Careers
    • Contact Us
    • Accessibility
    • Privacy & Policy Statements
Back to Top Upward arrow
TOP

© Columbia University

  • X
  • Instagram
  • Facebook
  • YouTube
  • LinkedIn